Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
europe
2
×
abbvie
alkermes
allergan
apps
artificial intelligence
biotech
boston blog main
boston top stories
buprenorphine
caldicott
cariprazine
clinical trials
data governance
deep learning
deepmind
deepmind health
eli lilly
europe blog main
europe top stories
fda
felipe jain
google
health
health care
jess fiedorowicz
jessica jeffrey
karim calis
life sciences
lumateperone
m health fairview
machine learning
marc goodman
massachusetts general hospital
medicine
national blog main
national health service
national institutes of health (nih)
national top stories
ndg
What
gain
2
×
agreement
alerts
alkermes
antipsychotic
app
applying
benefits
caveats
commonly
company
controversy
data
deal
deepmind
deployment
designed
diagnostic
division
drug
effect
expanding
favor
fda
google
health
hopes
inked
inks
learning
machine
management
medical
medicine
messaging
national
nhs
offer
ongoing
owned
Language
unset
Current search:
gain
×
europe
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@techcrunch.com
6 years ago
DeepMind Health inks another 5-year NHS app deal in face of ongoing controversy
